Main decisions at Global Fund’s 41st Board meeting include updated allocations methodology and restricted financial contributions
On 15-16 May 2019, the Global Fund Board held its 41st meeting in Geneva, Switzerland. GFO was present, with observer status. The main decisions made at the meeting, in chronological order, are described below.
The Global Fund’s Technical Evaluation Reference Group (TERG), the Technical Review Panel (TRP) and the Secretariat have jointly concluded that the allocation methodology used for 2017–2019 “is effectively delivering on its objectives by increasing funds to countries of higher burden and lower economic capacity while accounting for populations disproportionately affected by the three diseases.”
As Global Fund multi-country grants enter a new phase, we map all ongoing and planned regional and multi-country grants
In operationalizing its strategic initiatives, the Secretariat has ensured that each initiative has a “sharp focus” on deliverables and outcomes, with strong accountability for delivery, a spokesperson for the Secretariat says.
The Global Fund, the World Health Organization (WHO), the Stop TB Partnership and 13 countries with a high burden of TB have launched a program to find and treat an additional 1.5 million missing cases of TB by the end of 2019.
In our article, “More information on catalytic investments,” published on 17 April 2017 in GFO 309, we erroneously said that in order to access Matching Funds, a component of catalytic investments, countries must commit domestic funds equal to the matching amount requested. We wrote: “In addition, they must “match the Matching Funds” – i.e.
Two high-profile initiatives were launched late last year, each designed to shore up the response to the global tuberculosis epidemic.
Catalytic investments: $800 million for matching funds, multi-country approaches, and strategic initiatives
The Global Fund Board has approved $800 million to be set aside for catalytic investments over the 2017-2019 grant cycle. These investments are intended to catalyze country allocations to ensure they deliver results against the aims of 2017-2022 Global Fund Strategy.
Le Fonds mondial devrait aligner ses investissements à effet catalyseur aux objectifs mondiaux pour l'éradication du paludisme
En 2015, l'Organisation mondiale de la santé (OMS) indiquait que plus de la moitié des 106 pays où le paludisme continuait à se transmettre en 2000, avait réussi à faire baisser l’apparition de nouveaux cas d’au moins 75 %. Les investissements du Fonds mondial ont été, et continuent d'être, un facteur clé de ce succès.
The Global Fund should align its catalytic investments with global targets for malaria elimination and eradication
In 2015, the World Health Organization (WHO) reported that among the 106 countries with malaria transmission in 2000, more than half had achieved at least a 75% reduction in new cases. The Global Fund’s investments have been, and continue to be, a key driver of this success. Dedicated funding for malaria has dramatically reduced the malaria burden and sustained these reductions.